Delayed Presentation of Hepatocellular Liver Injury After Nintedanib Administration

被引:8
作者
Olin, Jacqueline L. [1 ]
Woods, J. Andrew [1 ]
Garner, Stuart J. [2 ]
机构
[1] Wingate Univ, Sch Pharm, Wingate, NC 28174 USA
[2] Novant Hlth Pulm & Crit Care, Charlotte, NC USA
关键词
D O I
10.1097/MJT.0000000000000464
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:E107 / E108
页数:2
相关论文
共 4 条
[1]   Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[2]  
[Anonymous], OFEV NINT PROD INF
[3]   Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis [J].
Richeldi, Luca ;
du Bois, Roland M. ;
Raghu, Ganesh ;
Azuma, Arata ;
Brown, Kevin K. ;
Costabel, Ulrich ;
Cottin, Vincent ;
Flaherty, Kevin R. ;
Hansell, David M. ;
Inoue, Yoshikazu ;
Kim, Dong Soon ;
Kolb, Martin ;
Nicholson, Andrew G. ;
Noble, Paul W. ;
Selman, Moises ;
Taniguchi, Hiroyuki ;
Brun, Michele ;
Le Maulf, Florence ;
Girard, Mannaig ;
Stowasser, Susanne ;
Schlenker-Herceg, Rozsa ;
Disse, Bernd ;
Collard, Harold R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2071-2082
[4]   Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review [J].
Teo, Yi Ling ;
Ho, Han Kiat ;
Chan, Alexandre .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (02) :231-242